EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS54 - Allergy diagnosis 13

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
5 Year Follow Up: Unveiling True Beta-Lactam Immediate Hypersensitivity in the University of Chile Clinical Hospital
A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre
Allergic diseases in children with autism spectrum disorders
Beta-Lactam Hypersensitivity: 5-year characterization of patients evaluated at the University of Chile Clinical Hospital
Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
Drug-Induced Enterocolitis Syndrome (DIES) Associated to Amoxicillin and Amoxicillin-Clavulanic Acid: A Growing Concern at a Tertiary Hospital
Erythematous-papular rash due to pseudoephedrine allergy: description of a clinical case
Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
Implementing Penicillin Delabelling in an Inpatient setting
Insights from Drug Provocation Testing in Quinolone Allergy
Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
Isoniazid-Induced Lupus in a Filipino Female: A Case Report
Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
Risk factors and molecular profiles of sensitization in infants with atopy in early ontogenesis
Synthetic folic acid allergy
The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital
Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists

Speakers